GRI Bio GRI
NASDAQ GRI
$1.71 +0.04 (+2.40%)
As of: Aug 21, 2026 · 10:12 AM EDT

GRI Bio (GRI) EPS (Basic) Growth (5y) (2025 - 2026)

GRI Bio (GRI) EPS (Basic) Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.29 Bn 78.30 Bn 3.93 Bn
3 Argenx Se 65.17 Bn 59.98 Bn 1.37 Bn
4 Moderna 61.38 Bn 56.24 Bn 52.00 Mn
5 BeOne Medicines 42.18 Bn 37.09 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.99 Bn 27.68 Bn 992.69 Mn
7 BioNTech SE 28.45 Bn 10.05 Bn 668.28 Mn
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 GRI Bio 3.09 Mn 3.09 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 92.68%
Dec 31, 2025 83.47%
Sep 30, 2025 83.91%
Jun 30, 2025 84.24%
Mar 31, 2025 78.87%